The overall goal of the Skeletal Phenotyping Core is to provide the highest quality assessment of skeletal characteristics in the most efficient manner. The core will provide investigators with access to state-of-the-art technology, training in use of new devices (as appropriate) and consultation on experimental design, data analysis and interpretation. Specifically, the core facilities and services will include: 1) peripheral dual-energy X-ray absorptiometry for in vivo assessment of bone mineral density and body composition in mice; 2) histology and histomorphometry, including in situ hybridization and immunohistochemistry; and 3) high resolution micro-computed tomographic (CT) imaging for 3D, non-destructive assessment of bone microarchitecture and morphology. By maintaining bone assessments within the core facility, high quality control standards can be readily maintained. By coordinating the bone analysis efforts, it will be possible, for example, to evaluate the same specimens first with mu CT (which is non-destructive) and then by histology and/or histomorphometry, thereby reducing the number of animals required for each experiment and enhancing the quality of data collected. The core will support Projects III, IV and V of the Program Project. However, it should be noted that establishment of this core will also serve many other investigators in the Endocrine Unit who have projects outside the Program Project. These investigators will have access to the core facilities and services, but will pay for these services in separate agreements with different fee structures than those provided to investigators within the Program Project.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK011794-39
Application #
7325713
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2006-12-01
Project End
2008-11-30
Budget Start
2006-12-01
Budget End
2007-11-30
Support Year
39
Fiscal Year
2007
Total Cost
$116,018
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Christov, Marta; Clark, Abbe R; Corbin, Braden et al. (2018) Inducible podocyte-specific deletion of CTCF drives progressive kidney disease and bone abnormalities. JCI Insight 3:
Dedic, Christopher; Hung, Tin Shing; Shipley, Alan M et al. (2018) Calcium fluxes at the bone/plasma interface: Acute effects of parathyroid hormone (PTH) and targeted deletion of PTH/PTH-related peptide (PTHrP) receptor in the osteocytes. Bone 116:135-143
Mizuhashi, Koji; Ono, Wanida; Matsushita, Yuki et al. (2018) Resting zone of the growth plate houses a unique class of skeletal stem cells. Nature 563:254-258
Hanna, Patrick; Grybek, Virginie; Perez de Nanclares, Guiomar et al. (2018) Genetic and Epigenetic Defects at the GNAS Locus Lead to Distinct Patterns of Skeletal Growth but Similar Early-Onset Obesity. J Bone Miner Res 33:1480-1488
Wein, Marc N; Foretz, Marc; Fisher, David E et al. (2018) Salt-Inducible Kinases: Physiology, Regulation by cAMP, and Therapeutic Potential. Trends Endocrinol Metab 29:723-735
Bastepe, Murat (2018) GNAS mutations and heterotopic ossification. Bone 109:80-85
Kim, Sang Wan; Lu, Yanhui; Williams, Elizabeth A et al. (2017) Sclerostin Antibody Administration Converts Bone Lining Cells Into Active Osteoblasts. J Bone Miner Res 32:892-901
Roszko, Kelly L; Bi, Ruiye; Gorvin, Caroline M et al. (2017) Knockin mouse with mutant G?11 mimics human inherited hypocalcemia and is rescued by pharmacologic inhibitors. JCI Insight 2:e91079
Grigelioniene, Giedre; Nevalainen, Pasi I; Reyes, Monica et al. (2017) A Large Inversion Involving GNAS Exon A/B and All Exons Encoding Gs? Is Associated With Autosomal Dominant Pseudohypoparathyroidism Type Ib (PHP1B). J Bone Miner Res 32:776-783
Balani, Deepak H; Ono, Noriaki; Kronenberg, Henry M (2017) Parathyroid hormone regulates fates of murine osteoblast precursors in vivo. J Clin Invest 127:3327-3338

Showing the most recent 10 out of 215 publications